EBR Systems (EBRCZ) Current Deferred Revenue (2025 - 2026)
EBR Systems (EBRCZ) posted Current Deferred Revenue of $1.1 million for Q1 2026, up 119.12% sequentially from $502000.0 in Q4 2025.
EBR Systems (EBRCZ) Current Deferred Revenue (2025 - 2026) Analysis & Trends
EBR Systems has reported Current Deferred Revenue for 2 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $502000.0, changed N/A from the prior year.
- Current Deferred Revenue rose to $1.1 million in Q1 2026 per EBRCZ's latest filing, from $502000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.1 million in Q1 2026 and troughed at $502000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | EBR Systems | 11.82 Mn | 11.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 502,000.00 |